Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Legendre

Showing results (211-220 of 366) with videos related to

Pageof 37
Sort By:
Kidney International|February 5, 2015
Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studiesChristoph Licht, Larry A Greenbaum, Petra Muus, et al.
The New England Journal of Medicine|June 7, 2013
Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndromeC M Legendre, C Licht, P Muus, et al.
Transplantation|April 4, 2020
Global Transplantation COVID Report March 2020C Ahn, H Amer, D Anglicheau, et al.
Physical Review Letters|May 16, 2007
Measurements of CP-violating asymmetries in B0-->a1+/-(1260)pi-/+ decaysB Aubert, M Bona, D Boutigny, et al.
Physical Review Letters|October 13, 2007
Search for the rare decay B-->pil+ l-B Aubert, M Bona, D Boutigny, et al.
Physical Review Letters|October 13, 2007
Production and decay of Omegac0B Aubert, M Bona, D Boutigny, et al.
Physical Review Letters|August 7, 2007
Observation of CP violation in B(0) --> K(+)pi(-) and B(0) --> pi(+)pi(-)B Aubert, M Bona, D Boutigny, et al.
Physical Review Letters|May 16, 2007
Branching fraction measurements of B+-->rho+gamma, B0-->rho0gamma, and B0-->omegagammaB Aubert, M Bona, D Boutigny, et al.
Physical Review Letters|March 16, 2007
Measurement of the B0-->pi(-l)(+nu) form-factor shape and branching fraction, and determination of /Vub/ with a loose neutrino reconstruction techniqueB Aubert, M Bona, D Boutigny, et al.
Physical Review Letters|November 13, 2007
Improved measurement of CP violation in neutral B decays to cc[over]sB Aubert, M Bona, D Boutigny, et al.
Pageof 37

Showing results (211-220 of 366) with videos related to

Sort By:
Pageof 37
Kidney International|February 5, 2015
Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studiesChristoph Licht, Larry A Greenbaum, Petra Muus, et al.
The New England Journal of Medicine|June 7, 2013
Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndromeC M Legendre, C Licht, P Muus, et al.
Transplantation|April 4, 2020
Global Transplantation COVID Report March 2020C Ahn, H Amer, D Anglicheau, et al.
Physical Review Letters|May 16, 2007
Measurements of CP-violating asymmetries in B0-->a1+/-(1260)pi-/+ decaysB Aubert, M Bona, D Boutigny, et al.
Physical Review Letters|October 13, 2007
Search for the rare decay B-->pil+ l-B Aubert, M Bona, D Boutigny, et al.
Physical Review Letters|October 13, 2007
Production and decay of Omegac0B Aubert, M Bona, D Boutigny, et al.
Physical Review Letters|August 7, 2007
Observation of CP violation in B(0) --> K(+)pi(-) and B(0) --> pi(+)pi(-)B Aubert, M Bona, D Boutigny, et al.
Physical Review Letters|May 16, 2007
Branching fraction measurements of B+-->rho+gamma, B0-->rho0gamma, and B0-->omegagammaB Aubert, M Bona, D Boutigny, et al.
Physical Review Letters|March 16, 2007
Measurement of the B0-->pi(-l)(+nu) form-factor shape and branching fraction, and determination of /Vub/ with a loose neutrino reconstruction techniqueB Aubert, M Bona, D Boutigny, et al.
Physical Review Letters|November 13, 2007
Improved measurement of CP violation in neutral B decays to cc[over]sB Aubert, M Bona, D Boutigny, et al.
Pageof 37